BWAY

SEC source: 0001171843-26-004216 · ownership.xml · nonDerivative · entry 3

Moiseyev Gilad · CIK 0002111634 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,098

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F5 · price: The sale price was NIS 42.0397 per share.

F3 · balance_after: This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.

SEC source: 0001171843-26-003899 · ownership.xml · nonDerivative · entry 4

Roth Yiftach · CIK 0002111635 · Chief Scientist

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,072,305

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F6 · price: The sale price was NIS 42.0035 per share.

F3 · balance_after: This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share.

SEC source: 0001171843-26-003899 · ownership.xml · nonDerivative · entry 3

Roth Yiftach · CIK 0002111635 · Chief Scientist

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,074,305

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F5 · price: The sale price was NIS 43 per share.

F3 · balance_after: This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share.

SEC source: 0001171843-26-003899 · ownership.xml · nonDerivative · entry 2

Roth Yiftach · CIK 0002111635 · Chief Scientist

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,075,305

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F4 · price: The sale price was NIS 43.45 per share.

F3 · balance_after: This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share.

SEC source: 0001171843-26-003899 · ownership.xml · nonDerivative · entry 1

Roth Yiftach · CIK 0002111635 · Chief Scientist

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,077,305

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The sale price was NIS 43.64 per share.

F3 · balance_after: This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share.

SEC source: 0001171843-26-003696 · ownership.xml · nonDerivative · entry 2

Mitrany Rayten Michal Ety · CIK 0002111631 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F4 · price: The sale price was NIS 44.7516 per share.

F3 · balance_after: This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.

SEC source: 0001171843-26-003696 · ownership.xml · nonDerivative · entry 1

Mitrany Rayten Michal Ety · CIK 0002111631 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,480

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The sale price was NIS 45.5588 per share.

F3 · balance_after: This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.

SEC source: 0001171843-26-004216 · ownership.xml · derivative · entry 4

Moiseyev Gilad · CIK 0002111634 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Ordinary Shares · 7,500 shares

Expires 2034-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The exercise price is NIS 11.17 per share.

F6 · derivative.exercise_date: Stock options were granted on March 5, 2024, with the remaining options to purchase 13,125 ordinary shares vesting in equal quarterly installments until March 5, 2028.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

SEC source: 0001171843-26-004216 · ownership.xml · nonDerivative · entry 2

Moiseyev Gilad · CIK 0002111634 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,098

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F4 · price: These shares were retained by the Company at a price of NIS 44.04 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person.

F3 · balance_after: This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.

SEC source: 0001171843-26-004216 · ownership.xml · nonDerivative · entry 1

Moiseyev Gilad · CIK 0002111634 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The exercise price is NIS 11.17 per share.

F3 · balance_after: This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.

SEC source: 0001171843-26-003596 · ownership.xml · derivative · entry 6

Mitrany Rayten Michal Ety · CIK 0002111631 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 17,500 shares

Expires 2028-01-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The exercise price is NIS 15.26 per share.

F6 · derivative.exercise_date: Stock options were granted on January 13, 2020, and were fully vested by November 28, 2023.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

SEC source: 0001171843-26-003596 · ownership.xml · nonDerivative · entry 4

Mitrany Rayten Michal Ety · CIK 0002111631 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,480

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F5 · price: These shares were retained by the Company at a price of NIS 43.92 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person.

F3 · balance_after: This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.

SEC source: 0001171843-26-003596 · ownership.xml · nonDerivative · entry 3

Mitrany Rayten Michal Ety · CIK 0002111631 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,560

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The exercise price is NIS 15.26 per share.

F3 · balance_after: This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.

SEC source: 0001171843-26-003596 · ownership.xml · derivative · entry 5

Mitrany Rayten Michal Ety · CIK 0002111631 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Ordinary Shares · 10,000 shares

Expires 2028-01-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The exercise price is NIS 15.26 per share.

F6 · derivative.exercise_date: Stock options were granted on January 13, 2020, and were fully vested by November 28, 2023.

F1 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

SEC source: 0001171843-26-003596 · ownership.xml · nonDerivative · entry 2

Mitrany Rayten Michal Ety · CIK 0002111631 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,060

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F4 · price: These shares were retained by the Company at a price of NIS 44.36 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person.

F3 · balance_after: This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.

SEC source: 0001171843-26-003596 · ownership.xml · nonDerivative · entry 1

Mitrany Rayten Michal Ety · CIK 0002111631 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F2 · price: The exercise price is NIS 15.26 per share.

F3 · balance_after: This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.